Strategy
AllerPharma is actively pursuing mid/late stage opportunities in the therapeutic areas of ophthalmology, dermatology, respirology, allergy, as well as other specialty areas.
Our in-house clinical and regulatory expertise and significant sales presence will allow us to participate in the development of future products, allowing us to deliver new products to the Canadian market.
Corporate Strategy- Build a specialized Canadian pharmaceutical company focused on allergy, dermatology, ophthalmology and respiratory treatments.
- Continue to grow our sales and marketing presence across Canada.
- Forge partnerships with biotechnology and pharmaceutical companies possessing late-stage or marketed products by offering:
- Expertise for Canadian product registration.
- Management of clinical studies that may be required for registration in Canada.
- Management of provincial formulary approvals and pricing (PMPRB) issues for Canadian markets.